Feed 1312.HK
13
Kontafarma China Holdings Ltd
1312.HK · HKSE
$0.03 -6.90% (-$0.00)
1M -3.33%
Market Cap $161.8M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.04
48.1% upside
Aktuální cena
$0.027
Podhodnoceno Férová hodnota Nadhodnoceno
Podle Bulios Fair Price je akcie 1312.HK aktuálně podhodnocená vůči své tržní ceně. Jak to funguje?
Valuation
100 /100
Cheap P/S 0.18x
P/B 0.29x
P/FCF 3.04x
Growth
19 /100
Declining Rev. growth 0.76%
Book val. growth 20.50%
EPS growth N/A
Profitability
33 /100
Weak Gross margin 56.15%
Net margin 46.77%
Op. margin 4.91%
Quality
15 /100
Poor ROIC 6.52%
ROA 40.17%
Asset turnover 0.86x
Debt
49 /100
Moderate Debt/Equity 0.37x
Current ratio 0.79x
Int. coverage -4.17x
Stability
41 /100
Moderate Beta -0.02x
Rev. volatility 10.24%
EPS volatility 251.31%
Zeptejte se StockBota na 1312.HK
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Feifei Wang
Employees
636
Headquarters
Hong Kong